Financial Performance - The company's operating revenue for Q3 2024 was ¥272,832,174.77, representing a 4.13% increase year-over-year, while the year-to-date revenue reached ¥841,219,740.08, up 14.28% compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2024 was ¥8,231,431.94, a decrease of 4.76% year-over-year, and the year-to-date net profit was ¥21,359,872.65, down 34.44% compared to the previous year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was ¥9,768,188.19, an increase of 43.17% year-over-year, with a year-to-date figure of ¥21,272,198.18, also up 43.30%[2]. - Total revenue for the third quarter reached ¥841,219,740.08, an increase of 14.26% compared to ¥736,122,067.81 in the same period last year[16]. - The total profit for Q3 2024 was CNY 27,094,809.06, down 26.8% from CNY 37,035,932.12 in the same period last year[17]. - Operating profit for Q3 2024 was CNY 27,572,163.55, a decline of 27.3% from CNY 37,963,397.93 in Q3 2023[17]. - The total comprehensive income for Q3 2024 was CNY 21,375,248.66, a decrease from CNY 32,571,262.12 in the same quarter last year[18]. Assets and Liabilities - The company's total assets at the end of Q3 2024 were ¥1,369,331,495.24, reflecting a 6.15% increase from the end of the previous year[2]. - The total liabilities increased to ¥671,633,726.29 from ¥588,543,349.99, representing a rise of 14.14%[15]. - Fixed assets grew significantly to ¥603,564,426.98 from ¥471,019,201.00, reflecting a substantial increase of 28.09%[14]. - The company's cash and cash equivalents increased to ¥58,417,320.08 from ¥51,172,415.92, representing a growth of 14.43%[13]. - Accounts receivable rose to ¥262,928,532.04, compared to ¥230,602,615.98 at the beginning of the period, indicating an increase of 14.00%[13]. - Inventory levels increased to ¥267,727,069.12 from ¥245,859,868.13, marking an increase of 8.85%[13]. Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥19,194,206.70, showing a significant decline of 85.27% year-over-year[2]. - Cash flow from operating activities for the current period was CNY 19,194,206.70, significantly lower than CNY 130,268,170.24 in the previous year[19]. - Cash flow from investment activities showed a net outflow of CNY 61,468,804.79, compared to a net outflow of CNY 52,938,147.89 in the same period last year[20]. - The company reported cash and cash equivalents at the end of the period amounting to CNY 44,017,320.08, an increase from CNY 39,197,202.57 at the end of Q3 2023[20]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 3,722[7]. - The largest shareholder, Zheng Licheng, holds 14.95% of shares, totaling 11,485,080 shares, with 3,000,000 shares pledged[7]. - The second-largest shareholder, Yang Wei, owns 11.75% of shares, amounting to 9,023,991 shares, with no shares pledged[7]. - The company has a significant number of shares under lock-up due to executive restrictions, with all major shareholders having their shares locked until June 2027[9]. - The company has established a unified action agreement among major shareholders, including Zheng Licheng, Yang Wei, and Zhao Guoquan[8]. Expenses and Costs - Sales expenses for Q3 2024 increased by 46.37% to ¥9,207,286.09, attributed to higher employee compensation and quality-related costs[6]. - Financial expenses surged by 79.94% to ¥10,283,509.06, mainly due to increased interest expenses on convertible bonds[6]. - Total operating costs amounted to ¥811,791,402.01, up from ¥709,011,282.34, reflecting a year-over-year increase of 14.48%[16]. Future Outlook - Future outlook includes continued investment in research and development, with R&D expenses reported at ¥29,678,893.88, slightly down from ¥31,203,140.23 last year[16]. - The company plans to grant a total of 3.3 million restricted stocks under the 2024 incentive plan, representing 4.30% of the total share capital of 76.8019 million shares[11]. - The first grant will consist of 2.7625 million shares, approximately 3.60% of the total share capital, accounting for 83.71% of the total granted rights[11].
金沃股份(300984) - 2024 Q3 - 季度财报